Synta66是一种钙离子通道 Orai (CRAC 的核心) 的有效抑制剂，适用于与钙信号传导相关的神经和免疫系统疾病的研究。

CRAC intermediate 1是一种药物中间体，常用于 CRAC 离子通道化合物的合成，广泛用于离子通道功能的研究。

CM4620 is a CRAC channel inhibitor to treat acute pancreatitis.

GSK-7975A is a potent and orally available CRAC channel inhibitor.

Tanshinone IIA sulfonate sodium is a water-soluble derivative of tanshinone IIA, which acts as an inhibitor of store-operated Ca2+entry (SOCE), and is used to treat cardiovascular disorders.

YM-58483 是一种选择性的钙释放活化钙通道（CRAC）抑制剂，对 Orai1 具有高亲和力，IC50 值为 10 nM。YM-58483 具有免疫调节和抗炎作用，可用于自身免疫性疾病和炎症相关疾病的研究。

NDMC101 is a potent osteoclastogenesis inhibitor and inhibits osteoclast differentiation via down-regulation of NFATc1-modulated gene express. NDMC101 is similar to the DPP4 substrate and is a significant inhibitor of early T-cell activation via DPP4 inhibition. NDMC101can be used for study of bone disorders, such as rheumatoid arthritis, and synovial inflammation et al .

MRS 1845 is a potent SOCE inhibitor with can block capacitative Ca2+ entry with IC50 value of 1.7μM in HL-60 cells.

GSK5498A is a selective small molecule blocker of CRAC channel(IC50=1 uM) and inhibit mediator release from mast cells, and pro-inflammatory cytokine release from T-cells in a variety of species.